ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
Clinical trial NCT04277221 · UNKNOWN
Trial details
- NCT number
- NCT04277221
- Sponsor
- Safe Save Medical Cell Sciences & Technology Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2022-12-31
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.